265 related articles for article (PubMed ID: 27756456)
1. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
2. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
[TBL] [Abstract][Full Text] [Related]
3. Onchocerca volvulus: The Road from Basic Biology to a Vaccine.
Lustigman S; Makepeace BL; Klei TR; Babayan SA; Hotez P; Abraham D; Bottazzi ME
Trends Parasitol; 2018 Jan; 34(1):64-79. PubMed ID: 28958602
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Suppression of Onchocerciasis Transmission in Bioko Island, Equatorial Guinea.
Moya L; Herrador Z; Ta-Tang TH; Rubio JM; Perteguer MJ; Hernandez-González A; García B; Nguema R; Nguema J; Ncogo P; Garate T; Benito A; Sima A; Aparicio P
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004829. PubMed ID: 27448085
[TBL] [Abstract][Full Text] [Related]
5. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.
Walker M; Stolk WA; Dixon MA; Bottomley C; Diawara L; Traoré MO; de Vlas SJ; Basáñez MG
Epidemics; 2017 Mar; 18():4-15. PubMed ID: 28279455
[TBL] [Abstract][Full Text] [Related]
6. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.
Walker M; Pion SDS; Fang H; Gardon J; Kamgno J; Basáñez MG; Boussinesq M
Clin Infect Dis; 2017 Nov; 65(12):2026-2034. PubMed ID: 29020189
[TBL] [Abstract][Full Text] [Related]
7. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
8. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
[TBL] [Abstract][Full Text] [Related]
9. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
Alley WS; van Oortmarssen GJ; Boatin BA; Nagelkerke NJ; Plaisier AP; Remme JH; Lazdins J; Borsboom GJ; Habbema JD
BMC Public Health; 2001; 1():12. PubMed ID: 11734070
[TBL] [Abstract][Full Text] [Related]
10. Accelerating river blindness elimination by supplementing MDA with a vegetation "slash and clear" vector control strategy: a data-driven modeling analysis.
Smith ME; Bilal S; Lakwo TL; Habomugisha P; Tukahebwa E; Byamukama E; Katabarwa MN; Richards FO; Cupp EW; Unnasch TR; Michael E
Sci Rep; 2019 Oct; 9(1):15274. PubMed ID: 31649285
[TBL] [Abstract][Full Text] [Related]
11. The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling: NTD Modelling Consortium Onchocerciasis Group.
NTD Modelling Consortium Onchocerciasis Group
Gates Open Res; 2019; 3():1545. PubMed ID: 31723729
[TBL] [Abstract][Full Text] [Related]
12. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
13. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
[TBL] [Abstract][Full Text] [Related]
14. [River blindness can be eliminated].
Brodwall K
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2394. PubMed ID: 19935954
[No Abstract] [Full Text] [Related]
15. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
16. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
17. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
18. Head nodding syndrome and river blindness: a parasitologic perspective.
Kaiser C; Pion S; Boussinesq M
Epilepsia; 2009 Oct; 50(10):2325-6. PubMed ID: 19785668
[No Abstract] [Full Text] [Related]
19. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
20. Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
Frempong KK; Walker M; Cheke RA; Tetevi EJ; Gyan ET; Owusu EO; Wilson MD; Boakye DA; Taylor MJ; Biritwum NK; Osei-Atweneboana M; Basáñez MG
Clin Infect Dis; 2016 Jun; 62(11):1338-1347. PubMed ID: 27001801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
